| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA3508856 | A | AUC of [14C] aliskiren hemifumarate following single oral dose of [14C] aliskiren hemifumarate at 500 mg.Kg-1 level in mouse | Mus musculus | 1 | ALA3508693 | organism-based format | FDA Approval Packages | |
| 2. | ALA3508857 | A | Tmax of [14C] aliskiren hemifumarate following single oral dose of [14C] aliskiren hemifumarate at 500 mg.Kg-1 level in mouse | Mus musculus | 1 | ALA3508693 | organism-based format | FDA Approval Packages | |
| 3. | ALA3508858 | A | Cmax of [14C] aliskiren hemifumarate following single oral dose of [14C] aliskiren hemifumarate at 500 mg.Kg-1 level in mouse | Mus musculus | 1 | ALA3508693 | organism-based format | FDA Approval Packages | |
| 4. | ALA3508862 | A | AUC of [14C] aliskiren hemifumarate following single intravenous dose of [14C] aliskiren hemifumarate at 10 mg.Kg-1 level in mouse | Mus musculus | 1 | ALA3508693 | organism-based format | FDA Approval Packages | |
| 5. | ALA3508863 | A | Tmax of [14C] aliskiren hemifumarate following single intravenous dose of [14C] aliskiren hemifumarate at 10 mg.Kg-1 level in mouse | Mus musculus | 1 | ALA3508693 | organism-based format | FDA Approval Packages | |
| 6. | ALA3508864 | A | Cmax of [14C] aliskiren hemifumarate following single intravenous dose of [14C] aliskiren hemifumarate at 10 mg.Kg-1 level in mouse | Mus musculus | 1 | ALA3508693 | organism-based format | FDA Approval Packages | |
| 7. | ALA3508866 | A | Plasma concentration of [14C] aliskiren hemifumarate in first 24h following single oral dose of [14C] aliskiren hemifumarate at 500 mg.Kg-1 level in mouse | Mus musculus | 1 | ALA3508693 | organism-based format | FDA Approval Packages | |
| 8. | ALA3508867 | A | Plasma concentration of [14C] aliskiren hemifumarate in first 4h following single intravenous oral dose of [14C] aliskiren hemifumarate at 10 mg.Kg-1 level in mouse | Mus musculus | 1 | ALA3508693 | organism-based format | FDA Approval Packages | |
| 9. | ALA3508868 | A | Biliary elimination of aliskiren following single oral dose of [14C] aliskiren hemifumarate at 500 mg.Kg-1 level in mouse | Mus musculus | 1 | ALA3508693 | organism-based format | FDA Approval Packages | |
| 10. | ALA3508869 | A | Biliary elimination of aliskiren following single intravenous dose of [14C] aliskiren hemifumarate at 10 mg.Kg-1 level in mouse | Mus musculus | 1 | ALA3508693 | organism-based format | FDA Approval Packages | |
| 11. | ALA3508870 | A | Faecal elimination of aliskiren following single oral dose of [14C] aliskiren hemifumarate at 500 mg.Kg-1 level in mouse | Mus musculus | 1 | ALA3508693 | organism-based format | FDA Approval Packages | |
| 12. | ALA3508871 | A | Faecal elimination of aliskiren following single intravenous dose of [14C] aliskiren hemifumarate at 10 mg.Kg-1 level in mouse | Mus musculus | 1 | ALA3508693 | organism-based format | FDA Approval Packages | |
| 13. | ALA3508872 | A | Excretion of radioactivity (0-24h) in urine following single oral dose of 500 mg.Kg-1 [14C] aliskiren hemifumarate in mouse | Mus musculus | 1 | ALA3508693 | organism-based format | FDA Approval Packages | |
| 14. | ALA3508873 | A | Excretion of radioactivity (0-24h) in urine following single intravenous dose of 10 mg.Kg-1 [14C] aliskiren hemifumarate in mouse | Mus musculus | 1 | ALA3508693 | organism-based format | FDA Approval Packages | |
| 15. | ALA3508874 | A | Excretion of radioactivity (0-24h) in faeces following single oral dose of 500 mg.Kg-1 [14C] aliskiren hemifumarate in mouse | Mus musculus | 1 | ALA3508693 | organism-based format | FDA Approval Packages | |
| 16. | ALA3508875 | A | Excretion of radioactivity (0-24h) in faeces following single intravenous dose of 10 mg.Kg-1 [14C] aliskiren hemifumarate in mouse | Mus musculus | 1 | ALA3508693 | organism-based format | FDA Approval Packages | |
| 17. | ALA3508876 | A | Mean excretion of radioactivity (0-24h) in urine and faeces following single oral dose of 500 mg.Kg-1 [14C] aliskiren hemifumarate in mouse | Mus musculus | 1 | ALA3508693 | organism-based format | FDA Approval Packages | |
| 18. | ALA3508877 | A | Mean excretion of radioactivity (0-24h) in urine and faeces following single intravenous dose of 10 mg.Kg-1 [14C] aliskiren hemifumarate in mouse | Mus musculus | 1 | ALA3508693 | organism-based format | FDA Approval Packages | |
| 19. | ALA3508878 | A | Excretion of radioactivity (24-48h) in urine following single oral dose of 500 mg.Kg-1 [14C] aliskiren hemifumarate in mouse | Mus musculus | 1 | ALA3508693 | organism-based format | FDA Approval Packages | |
| 20. | ALA3508879 | A | Excretion of radioactivity (24-48h) in urine following single intravenous dose of 10 mg.Kg-1 [14C] aliskiren hemifumarate in mouse | Mus musculus | 1 | ALA3508693 | organism-based format | FDA Approval Packages |
The page will load shortly, Thanks for your patience!